Verve Gets OK from FDA to Test Gene Editing, Expands Lilly Relationship

Posted by ISPE Boston
On November 2, 2023

Verve Therapeutics has announced the lifting of the clinical hold and clearance of its Investigational New Drug (IND) application by the FDA to conduct a clinical trial evaluating Verve-101 for the treatment of heterozygous familial hypercholesterolemia (HeFH). Verve-101 is an investigational, in vivo base editing medicine designed to be a single-course treatment that inactivates the […]

Beam’s Cost Cutting, Deal with Lilly to Provide Breathing Room into 2026

Posted by ISPE Boston
On November 2, 2023

Beam Therapeutics has announced portfolio priorities and plans to streamline its business operations including a reduction in headcount of approximately 100 employees, about 20% of its current workforce, which is anticipated to be completed in the fourth quarter of 2023. In related news, Beam also reported it expects to receive $250 million from Eli Lilly […]

ARPA-H Initiative Invests to Improve Clinical Trials

Posted by ISPE Boston
On November 2, 2023

The Advanced Research Projects Agency for Health (ARPA-H), an agency within the Department of Health and Human Services (HHS), is taking action to improve the nation’s ability to conduct clinical trials safely, quickly, and equitably and to improve clinical trial access for people in communities across the country as the first initiative within the recently […]

2023 FALL GOLF AT INDIAN POND!

Posted by ISPE Boston
On October 30, 2023

On Monday, October 23rd, ISPE members and guests gathered once again to participate in the Annual Fall Golf Tournament to benefit the ISPE Scholarship Foundation at the picturesque Indian Pond Country Club. Many golfers kicked off the scramble format tournament by pumping some tunes through their new ISPE branded tumblers with built in waterproof bluetooth […]

Career Panel and Networking Event

Posted by ISPE Boston
On October 25, 2023

The Career Panel and Networking Event was hosted by Northeastern University’s Graduate Women in Science and Engineering, ISPE Boston’s Ethnocultural Diversity, Equity, and Inclusion Committee, and ISPE Boston’s Student Development Committee at Northeastern University. The event was attended by both undergraduate and graduate students who are interested in the biotech and pharma industries. During the […]

Product Show Attracts Thousands on September 20th

Posted by ISPE Boston
On October 19, 2023

Last month, on Wednesday, September 20th, 2023, we hosted our 31st Annual Product Show at Gillette Stadium! And honestly, it was the biggest, best show we have had yet. We are just now recovering. There was record attendance once again, beating out last year’s attendance with over 4,500 attendees! Our new mobile app helped people […]

New Map of the Brain to Help Treat Disease

Posted by ISPE Boston
On October 19, 2023

A group of international scientists have mapped the genetic, cellular, and structural makeup of the human brain and the nonhuman primate brain. This understanding of brain structure allows for a deeper knowledge of the cellular basis of brain function and dysfunction, helping pave the way for a new generation of precision therapeutics for people with […]

Vertex Researchers Awarded “Breakthrough Prize in Life Sciences”

Posted by ISPE Boston
On October 12, 2023

Three Vertex researchers have been awarded the 2024 Breakthrough Prize in Life Sciences “for developing life-transforming drug combinations that repair the defective chloride channel protein in patients with cystic fibrosis.” The award celebrates the work of Paul Negulescu, Ph.D., Fredrick Van Goor, Ph.D., and Sabine Hadida, Ph.D., who have worked together to lead cystic fibrosis […]

Sanofi and Teva to Collaborate on Treatment for Inflammatory Bowel Disease

Posted by ISPE Boston
On October 12, 2023

Sanofi and Teva Pharmaceuticals have entered into a collaboration to co-develop and co-commercialize TEV’574, currently in Phase 2b clinical trials for the treatment of ulcerative colitis and Crohn’s disease, two types of inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract. An estimated 10 million people worldwide live with IBD. According to […]

Chapter Member Anniversaries: October 2023

Posted by ISPE Boston
On October 4, 2023

Please congratulate the following members celebrating milestone anniversaries in October 2023. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Mark Caswell, Lonza Biologics Inc Louis Cicchese, Moderna Therapeutics Aaron Conant, Alnylam Pharmaceuticals Patrick Cunneen, Techniserv Inc William Devine, Pharma-Tech Services Jason Dollarhide, Hodess Cleanroom Construction Peter Falk, […]

Page 17 of 118«‹15 161718 19 ›»